The RTS, S/AS01E malaria vaccine, introduced through routine childhood immunisation programmes in Ghana, Kenya and Malawi, led to a substantial decline in child mortality over four years, a study said. (File Photo) A landmark real-world study published in The Lancet has found that the world’s first approved malaria vaccine reduced overall child deaths by 13 per cent in parts of Africa, providing the strongest evidence yet that immunisation can significantly reduce mortality. The World Health Organisation (WHO) has hailed the findings as a major milestone in the global fight against malaria and a sign that eliminating the disease within this generation is an achievable goal. The study found that the RTS, S/AS01E malaria vaccine, introduced through routine childhood immunisation programmes in Ghana, Kenya and Malawi, led to a substantial decline in child mortality over four years.…